| AbbVie AG - ELAHERE 100 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 69700 | | 01 | | ELAHERE 100 mg/20 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX26 | | Mirvetuximab Soravtansine | | 13.03.2025 | | |
|
| Composition |
| mirvetuximabum soravtansinum 100 mg, acidum aceticum, polysorbatum 20, natrii acetas corresp. natrium 2.94 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 20 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Mirvetuximabum Soravtansinum | 100mg / 20ml |
| | BAG: Active Agent | Dose |
|---|
| Mirvetuximabum Soravtansinum | 100 mg |
| | | | Inactive agents |
|---|
| Acetic Acid | | Sodium Acetate | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3106.01 | 3394.40 | A | SL | No |
|
